Table 4.

AMS questionnaire characteristics of the placebo, low- and high dose probiotic groups.

	Placebo			Low dose			High dose
	Baseline	6 weeks	12 weeks	Baseline	6 weeks	12 weeks	Baseline	6 weeks	12 weeks
Somatic	12.89 ± 3.98	10.82 ± 3.30	10.12 ± 2.93	10.26 ± 2.6	9.57 ± 2.34	10.14 ± 2.77	13.75 ± 4.60	11.88 ± 3.59	12.20 ± 3.91
Psychologic	7.06 ± 2.62	6.24 ± 2.36	5.94 ± 1.75	6.57 ± 1.50	5.95 ± 1.49	5.71 ± 0.99	6.81 ± 2.17	6.94 ± 2.72	6.87 ± 2.29
Sexual	10.78 ± 3.81	10.29 ± 4.47	9.24 ± 3.61	11.43 ± 3.63	9.36 ± 3.18	9.43 ± 3.92	10.69 ± 3.26	10.06 ± 2.89	10.67 ± 3.37
Total	30.72 ± 8.84	27.35 ± 9.04	25.29 ± 7.60	28.54 ± 7.37	24.40 ± 6.20	24.73 ± 7.15	31.25 ± 8.34	28.88 ± 7.39	29.73 ± 7.18